Table 2.
Monoclonal antibody-mediated cytokine immunoneutralization | IL-1, IL-6, TNF-α, IL-12, IL-23/IL-23, IL-17, IFN-α |
Modified cytokine receptors: competitive inhibitors | CTLA-4, TNF-α Rc |
Upstream drugs with efficacy through cytokine attenuation | Syk, S1P, BLyS, JAK |
Immunomodulating cytokines as therapeutic agents | IL-10, TGF-β |
Cytokine gene therapy | IL-1Ra |
CTLA-4, cytotoxic T lymphocyte antigen-4; Rc, receptor; Syk, spleen tyrosine kinase; BLyS, B lymphocyte stimulator; JAK, Janus kinase.